Portfolio company
4DMT
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops targeted gene therapy medicines for patients with severe genetic and retinal diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
4D Molecular Therapeutics
This digital health company develops precision gene therapies for patients with retinal, pulmonary, and cardiac diseases using a proprietary vector evolution platform.
GenSight Biologics
This company develops gene therapies for patients suffering from neurodegenerative retinal diseases and central nervous system disorders.
Adverum Biotechnologies
The company develops ocular gene therapies to treat retinal diseases for patients with vision-threatening conditions such as wet age-related macular degeneration.
PulseSight Therapeutics
This company develops non-viral gene therapies for patients with severe eye diseases including age-related macular degeneration.
Coave Therapeutics
The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.
Nightstar
This company develops gene therapies for patients with rare inherited retinal diseases that cause progressive blindness.
Atsena
This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.
Rocket Pharma
This company develops gene therapies for patients with rare and devastating genetic cardiovascular and haematological diseases.